The “United States Vaccines Market Size, Share, Growth Opportunities, Future Trends, Top Key Players, and Forecast to 2026” provides a comprehensive analysis of the fast-evolving, high-growth united states vaccines market. The report offers the most up-to-date industry data on the actual market situation and future outlook for the united states vaccines market. The report provides historical market data for 2015 – 2018, and forecasts from 2019 till 2026.

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2026. The report provides clear insight into current and future developments of the united states vaccines market. The report also explores the detailed analysis of the leading 27 vaccines market assessments in the united states from 2015 to 2018 and forecasts to 2026. A comprehensive analysis has been done on market share with percentage of the leading 27 vaccines. The report also details the latest information about the vaccine’s pricing trends and regulatory framework of the united states vaccine market.

Key trends in terms of collaboration, partnerships, merger & acquisition, distribution, exclusive and licensing agreement are analyzed with details. The report also examines the main market growth driving and restraining forces and also gives an all-round future outlook through 2026.

The report concludes with the profiles of the key players in the united states vaccines market. The key players are evaluated on various parameters such as business overview, vaccines portfolio, promising vaccines in the clinical development, and recent development.

The major companies dominating this market for its products, services, and continuous product developments are:

Pfizer

Merck

Sanofi Pasteur

Grifols

GlaxoSmithKline (GSK)

Dynavax Technologies Corporation

The following 27 leading vaccines of the united states vaccines market are detailed with market size and seven-years forecast

Prevnar / Prevnar 13

Gardasil / Gardasil 9

Fluzone

Flublok

Flucelvax Quadrivalent

Afluria Quadrivalent

Fluad

Varivax

Menactra

Proquad

Pneumovax 23

Fluarix/FluLaval

Havrix/Twinrix/Engerix–B

M–M–R II

Adacel

Boostrix

Bexsero

Menveo

Trumenba

Shingrix

Pentacel

Recombivax HB

Rotateq

Rotarix

Pediarix/Infanrix

Heplisav–B

TDVAX

Key Topics Covered in the Report:

The Market Size of the United States Vaccines Market with Seven Years Forecast

The Market Size of the 27 Leading Vaccines with Seven Years Forecast

Thoroughly Evaluates Market Share of the 27 Leading Vaccines in the US Vaccines Market

Provides Comprehensive Insights on the Latest Vaccines Pricing Trends and Analysis

Detailed Insights of the Regulatory Framework of the US Vaccines Market

Investigates the Key Growth Drivers and Restraints of the United States Vaccines Market

Provides Key Trends with Respect to Collaboration, Partnerships, Merger & Acquisition, Distribution, Exclusive and Licensing Agreement

A Comprehensive List of the Key Players Along with the Analysis of their Current Vaccines Portfolios, Promising Vaccines in the Clinical Development, and Recent Development

The Report Helps Answer the Following Questions: